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Since the first laparoscopic gastrectomy for cancer was reported in 1994, minimally invasive surgery is enjoying its wide acceptance. 
Numerous procedures of this approach have developed, and many patients have benefited from its effectiveness, which has been re-
cently demonstrated for early gastric cancer. However, since laparoscopic surgery is not exempt from some limitations, the robotic sur-
gery system was introduced as a solution by the late 1990’s. Many experienced surgeons have embraced this new emerging method 
that provides undoubted technical and minimally invasive advantages. To date, several studies have concentrated to this new system, 
and have compared it with open and laparoscopic approach. Most of them have reported satisfactory results concerning the post-op-
erative short-term outcomes, but almost all believe that the role of robotic gastrectomy is still out of focus, especially because long-term 
outcomes that can prove robotic oncologic equivalency are lacking, and operative costs and time are higher in comparison to the open 
and laparoscopic ones. This article is a review about the current status of robotic surgery for the treatment of gastric cancer, especially, 
focusing on the technical aspects, comparisons to other approaches and future prospects.
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Introduction
Minimally invasive approaches for gastric cancer is gaining 
worldwide increasing acceptance. Laparoscopic surgery, introduced 
by the 1980’s, is widely accepted and currently mainstreamed as a 
minimally invasive approach for many general surgery procedures, 
including gastrectomy especially for early gastric cancer (EGC). 
Since the first case of a laparoscopic gastrectomy (LG) for cancer 
was reported in 1994, surgeons with sufficient experience in open 
gastric surgery adopted this new approach for EGC: it offers not 
only better early post-operative course but also long-term onco-
logic outcomes comparable to those achieved with open gastrec-
tomy (OG).(1-3) 
However, laparoscopic surgery is not exempt from several dis-
advantages, such as altered operating view, lack of versatility in 
surgical instrumentation and an indication to treat advanced gastric 
cancers still to be defined. In an effort to minimize the limitations 
of laparoscopy, robotic surgery was introduced by the late 1990’s; 
thought this system provides undoubted technical advantages,(4) its 
role for gastric cancer is still unclear.(5-7) 
Since robotic gastrectomy (RG) has been reported,(4,8) the ap-
plication of this new approach is increasing in experienced centers 
but, up to date, a limited number of single case studies and not 
randomized comparative studies have focused on this new method. 
The purpose of this article is to review the current status of robotic 
surgery for gastric cancer, its technical aspects, its comparisons with 
open and laparoscopic surgery and to suggest future prospects.
Technical Aspects 
1. Indications
The indications for RG are the same as those for laparoscopic 
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ones(8-10): minimally invasive surgery (MIS) is indicated for EGC 
and it is based on the recommendations of the Japanese gastric 
cancer treatment guidelines and classification(11,12) as well as the 
fact that the oncological safety of MIS for advanced gastric cancer 
remains controversial. According to the articles present in literature 
up to date, we can summarize as follow:
- Indications for RG with limited lymphadenectomy: STAGE 
IA.
- Indications for RG requiring D2 lymphadenectomy: STAGE 
IB-IIA.
Mucosal and submucosal tumor, if eligible, is first considered 
for endoscopic resection. In case of failed attempts or not suit-
able to this approach, it can be a candidate for a RG with limited 
lymphadenectomy. Specific exclusion criteria or contraindications 
for robotic surgery, as for laparoscopic surgery, include intoler-
ance to pneumoperitoneum and oncologically contraindicated pre-
operative findings of T4b cancers or distant metastases.
2. Operative strategy
Specific characteristics of robotic surgical system and operating 
room configuration have been previously described in detail.(4,8-
10,13-17) Most of authors share port placement modality, except 
some minor variations. Briefly, it can be summarized as follow:
- The patient is in a supine position like in conventional lapa-
roscopy;
- The camera port is inserted at the umbilicus;
- Pneumoperitoneum of 12 mmHg is achieved and patient is 
then placed in the reverse Trendelenburg position about 15 
degrees;
- Under direct visualization, two ports (8 mm diameter) are in-
serted in the bilateral hypochondriac regions and two further 
ports (respectively, 8 mm and 12 mm diameter) are placed at 
both sides of the lateral abdomen, exception for minor adjust-
ments for the patient’s body habitus, relative locations of the 
intraabdominal organs and distance to the oesophageal hiatus 
during total gastrectomies.(17)
The patient-side cart is now moved next to the patient and the 
robotic arms are connected to the ports (Docking procedure). Sur-
geon holds the curved bipolar Maryland forceps by the first arm 
and the ultrasonic shears (or a monopolar device) and the Cadiere 
forceps by the second and the third arm.
Before proceeding with the main surgical steps, operative field 
needs to be prepared at least with three manoeuvres:
- Gastric decompression with insertion of nasogastric tube or 
alternatively with a 9 cm long 19 gauge needle introduced 
percutaneously, in case of gastric distension.(18)
- Liver retraction, with one of the various methods described up 
to date,(19-21) is a prerequisite for complete exposure of the 
anterior surface of the hepatogastric ligament.
- Intra-operative tumor localization in order to determine the 
resection extent during distal subtotal gastrectomy achieved 
by dye injection, intra-operative endoscopy,(8) or laparo-
scopic ultrasound,(9,22) or endoclips placement and then 
abdominal X-ray evaluation.(23) 
The following are the main surgical steps respectively for robotic 
subtotal gastrectomy and total gastrectomy.
1) D2 lymph node (LN) dissection during distal subtotal 
gas trectomy (numbers are LN stations according to 
Japanese Classification(11)):
• Partial incomplete omentectomy and left side dissection of the 
greater curvature: left gastroepiploic vessels.
• Right side dissection of the greater curvature and duodenal 
transection: head of pancreas and rightgastroepiploic vessels 
(LN #4s, 4sb).
• Hepatoduodenal ligament dissection and approach to supra-
pancreatic area: right gastric artery, proper hepatic artery, 
portal vein, common hepatic artery and celiac axis (LN #5, 
12a, 8a, 9).
• Exposure of the root of the left gastric artery and skeletoniza-
tion of the splenic vessels (LN #7, 11p).
• Lesser curvature dissection: oesophageal crus and cardia (LN 
#1, 3); proximal gastric resection.
2) D2 lymphadenectomy during total gastrectomy
All steps are as same as for distal gastrectomy except follow-
ings:
(1) Spleen-preserving total gastrectomy
• Dissection of the distal splenic vessels (LN #11d), the splenic 
hilum (LN #10), and the division of the short gastric vessels 
(LN #2, 4sa).
(2) Total gastrectomy with splenectomy
• Full mobilization of the distal pancreas and the spleen.
Reconstruction of gastrointestinal continuity can be achieved 
according to resection extent and surgeon’s preference as follows:
• Gastroduodenostomy, gastrojejunostomy, or Roux-en-Y gas-
trojejunostomy.
• Intracorporeal(4,9,14,24,25) or extracorporeal(9,14,26) gastro-
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intestinal anastomosis.
• Linear or circular staplers including transoral anvil placement.
3. Skill
1) What skills can be improved with robotic technology?
The robotic surgery system facilitates the process of performing 
laparoscopic surgery and provides:
• Three dimensional  (3D)- image;
• An intuitive translation of the instrument handle to the tip 
movement, thus eliminating the mirror image effect;
• Coaxial alignment of the eyes, hands, and tool tip image;
• Motion scaling;
• Tremor filtering;
• An internal articulated endoscopic wrist, providing an addi-
tional three degrees of freedom.
This computer-enhanced surgical system thus allows surgeons 
to overcome various difficulties during endoscopic surgery.(4,8)
2) Dissection of splenic vessels
The small branches of the splenic vessels are easily identified 
and preserved allowing a pancreas-spleen-preserving D2 lymph-
node dissection thank to image magnification, tremor filtering, 
fine circumferential robotic arm movements. This approach allows 
surgeons to drive the vascular dissection around and to completely 
clear the lymphatic tissue without any vascular injury with minimal 
intra-operative bleeding.(13,14)
3) Isolation of diaphragmatic crura
It’s a fundamental step to an en bloc dissection of cardia lymph-
nodes and is greatly facilitated by wristed instruments that allow 
complete encircling of the distal oesophagus.(13,15) Moreover, the 
four-arms robotic surgery system will facilitate the insertion of the 
anvil head into the oesophageal stump that could be not so easy 
to do in conventional laparoscopy,(15) and oesophagojejunostomy, 
which is usually performed in the deep and narrow space of the 
abdominal cavity, is feasible to execute by the robot-sewing tech-
nique.(27)
4) Lymphadenectomy include LN #14v, #8a, #9, #11p, 
#11d, #12a
Relatively difficult areas to access during laparoscopic lymphad-
enectomy include LN #14v, #8a, #9, and #11. Moreover, the infra-
pyloric area and the superior mesenteric vein, including stations 6 
and 14v, are the most frequent sources of intra-operative bleeding, 
while the suprapancreatic area including stations 7, 8a, and 9 is the 
second most frequent source.(13,26) If the dissection along these 
vessels is easily conducted, the risk of bleeding can be reduced 
and lymphadenectomy can be better performed. The EndoWrist, 
tremor filtration, stable operative platform, and three-dimensional 
vision offered by the robotic surgical system aid the surgeon to 
perform a more accurate lymph nodes and vessels dissection.(26)
Some authors have recently reported a new integrated robotic 
approach for suprapancreatic D2 nodal dissection which appears 
to be safe and feasible, even though the number of patients in the 
study was small.(28) Actually, the role of No. 14v lymphadenec-
tomy in distal gastric cancer is controversial. Dissection of node 
No. 14v had been a part of D2 gastrectomy defined by the 2nd 
edition of the Japanese classification, but it has been excluded from 
the latestedition.(11) However, D2 (+No. 14v) may be beneficial in 
tumors with apparent metastasis to the No. 6 nodes.
5) Lymphadenectomy in obese and bleeding control
Lymph node dissection around infrapyloric and suprapancreatic 
area is very difficult to perform in patients with a high body mass 
index (BMI). Robotic technology may facilitate laparoscopic ex-
tended lymphadenectomy in patients who have higher BMI than 
their Asian counterparts.(16,26)
The surgeon can more clearly and definitely identify and easily 
catch the bleeding vessels using this robotic system than in con-
ventional endoscopic surgery without such a robotic system. This 
is mainly due to the fact that the robotic system provides a three-
dimensional view and has few limitations in the movement of the 
instruments.(8)
Current Status
In recent years, phase III clinical trials provided evidence that 
LG with lymph node dissection is a safe and effective surgical pro-
cedure for the therapy of EGC(6): it produces a better early post-
operative course than conventional OG and the long-term outcome 
of laparoscopy is also similar to that of open surgery. In an effort to 
minimize the short comings of laparoscopy, especially the techni-
cal ones, the robotic surgery system was introduced as a solution. 
It is actually considered as a new technology that holds significant 
promises for the treatment of gastric cancer, although scientific 
evidence is still lacking.
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1. Single case studies
Since 2003 some surgeons started to embrace this new ap-
proach. If we consider only caseseries about RG for gastric cancer 
present in literature, ten reports, with a total of 299 patients, can be 
collected from 2007 up to date (Table 1).(9,13,15-17,27-31) 
The largest study is that of Song et al.(9) published in 2009 about 
their initial 100 cases of robot-assisted gastrectomy with lymph 
node dissection followed by another one(17) in 2011 with 61 pa-
tients. Total and subtotal robotic gastrectomies were performed with 
D1+ or/D2 lymphadenectomy according to specific case, on the 
basis of oncological criteria. Only EGC were included, exception for 
2 reports(13,15) that considered also advanced gastric cancer. Three 
series did not give any information about depth of invasion of the 
tumor. Each article reports pathologic findings of the enrolled co-
hort and short-term outcomes including operative details and post-
operative course; furthermore, each author describes in details the 
operative procedure of its own equipe.
In general, all these reports appear to verify the safety and fea-
sibility of this new technology by providing examples of how the 
robotic surgical system can produce maximum benefits.
RG with D2-lymphadenectomy allows achieving an adequate 
lymph node harvest and optimal R0-resection rates with low post-
operative morbidity and short hospital stays.(13,16,30)
Most common robotic disadvantages shared by most of authors 
are: longer operative time, higher costs, loss of tactile sensation, 
indication and lack of oncological results. Obviously, they underline 
that longer follow-up time and randomized studies are needed to 
evaluate long-term outcome and clinical advantages.
2. Comparative studies
Several retrospective comparative studies from Europe and 
Asia have evaluated the use of RG compared with laparoscopic or 
open ones. In general, they all share the concept that RG with D2 
lymph-node dissection is safe, technically feasible for experienced 
laparoscopic surgeons. On the one hand it’s oncologically effective 
compared to open surgery,(32) associated with less operative blood 
loss and shorter post-operative hospital stay than laparoscopic and 
open gastrectomy(33); on the other hand there are still some un-
resolved issues related to this new technology(5): longer operation 
time, loss of tactile sensation, higher costs, indications, oncologic 
equivalency to its counterparts.
1) Robotic vs. open gastrectomy
To date, only two articles compared RG with OG for gastric 
cancer (Table 2). Pernazza et al.(34), in their preliminary experi-
ence, compare for the first time survival, after 26 months of mean 
follow-up, between these 2 groups and show that robotic surgery 
may produce some long-term benefits, more evident in patients 
with advanced disease. At the end of the learning curve, difference 
in procedure duration is not statistically significant between the 
2 groups. Peri-operative morbidity seems to be higher in robotic 
group, mostly related to the esophagojejunal anastomosis. Post-
operative mortality rates are higher in conventional group, mainly 
in complicated courses with re-operation, probably due to major 
surgical trauma and immunologic stress, as demonstrated in other 
studies. Authors believe that robotic D2 lymphadenectomy is con-
vincing, easier than in laparoscopy, and as accurate as in open sur-
gery.
In the second study published up to date,(32) based on a strictly 
matched-case controlled method, no significant difference was 
shown to exist between the number of lymph nodes obtained 
during the laparoscopic and open procedures. When a precise 
lymphadenectomy is needed, robotic system takes advantage of its 
technologies that makes it possible to perform the dissection with 
greater ease. In addition, all resected margins in this study were free 
of tumour in the robotic group, whereas tumour involvement was 
present in the margin of two specimens in the open group. They 
furthermore identified less blood loss and a significantly shorter 
length of hospital stay thus favouring the minimally invasive ap-
proach, although surgery took longer for RG than for the OG 
group. While robotic procedures were associated with longer op-
erative times, there was no difference in 30 day morbidity or mor-
tality between treatment groups. Short-term follow-up evaluation, 
albeit still in a preliminary setting, showed no difference in survival 
rates between the two approaches. The conclusion of this trial is 
that robot-assisted gastric with D2 lymph node dissection is safe, 
technically feasible and oncologically effective compared to open 
surgery.
2) Robotic vs. laparoscopic gastrectomy
Only in recent years, some authors published their results about 
the comparison of RG versus LG (Table 3). Patients enrolled in 
these studies, are affected by EGC exception for those included in 
one article(35) that describes encouraging results with a low con-
version rate and any intra-operative complications for advanced 
gastric stages. All these trials evaluate patient characteristics, intra-
operative factors, postoperative complications and oncologic pa-
rameters.
Marano A and Hyung WJ
68
Ta
bl
e 3
. N
on
-ra
nd
om
ize
d c
lin
ica
l t
ria
ls 
ro
bo
tic
 vs
. la
pa
ro
sc
op
ic 
ga
str
ec
to
m
y f
or
 ga
str
ic 
ca
nc
er
Au
th
or
Ye
ar
Co
un
try
Ty
pe
 of
 
ap
pr
oa
ch
Sa
m
pl
e
Ty
pe
 of
 su
rg
er
y 
(T
G/
ST
G)
LN
 d
iss
ec
tio
n 
(D
1+
α 
or
 β
/D
2)
O
T 
(m
in
)
Bl
oo
d 
lo
ss 
(m
l)
Nu
m
be
r o
f r
es
ec
ted
 
LN
H
os
pi
ta
l s
ta
y 
(d
)
M
or
bi
di
ty
 
(%
)
Pu
gli
es
e e
t a
l.(
25
)
20
10
Ita
ly
R
18
0/
18
0/
18
34
4±
62
 (2
40
~4
60
)
90
±4
8 (
50
~2
00
)
25
±4
.5 
(1
8~
40
)
10
±3
 (1
0~
13
)
6
L
52
0/
52
0/
52
23
5±
23
 (1
45
~3
60
)
14
8±
53
 (4
5~
25
0)
31
±8
 (2
0~
45
)
10
±2
.6 
(7
~2
4)
12
.5
Eo
m
 et
 al
.(3
5)
20
12
Ko
re
a
R 
30
0/
30
10
/2
0
22
9.1
 (1
65
~3
07
)
15
2.8
 (1
0~
50
0)
30
.2 
(1
3~
60
)
7.9
 (7
~2
0)
13
L
62
0/
62
28
/3
4
18
9.4
 (1
25
~2
72
)
88
.3 
(1
0~
40
0)
33
.4 
(1
0~
67
)
7.8
 (5
~1
7)
6
W
oo
 et
 al
.(3
6)
20
11
Ko
re
a
R
23
6
62
/1
72
13
1/
10
5
21
9.5
91
.6 
39
.0
7.7
11
L
59
1
10
8/
48
1
31
2/
27
9
17
0.7
14
7.9
37
.4
7.0
13
.7
Yo
on
 et
 al
.(3
7)
20
12
Ko
re
a
R
36
36
/0
- 
  3
05
.8±
11
5.8
- 
42
.8±
12
.7
8.8
±3
.3
16
.7
L
65
65
/0
- 
21
0.2
±5
7.7
- 
39
.4±
13
.4
10
.3±
10
.8
15
.4
R 
= 
ro
bo
tic
; L
 =
 la
pa
ro
sc
op
ic;
 T
G 
= 
to
ta
l g
as
tre
cto
m
y; 
ST
G 
= 
su
bt
ot
al 
ga
str
ec
to
m
y; 
LN
 =
 ly
m
ph
 n
od
e; 
O
T 
= 
op
er
ati
ve
 ti
m
e. 
Ta
bl
e 4
. N
on
-ra
nd
om
ize
d c
lin
ica
l t
ria
ls 
ro
bo
tic
 vs
. la
pa
ro
sc
op
ic 
vs
. o
pe
n g
as
tre
cto
m
y f
or
 ga
str
ic 
ca
nc
er
Au
th
or
Ye
ar
Co
un
try
Ty
pe
 of
 
ap
pr
oa
ch
Nu
m
be
r o
f 
pa
tie
nt
s
Ty
pe
 of
 su
rg
er
y 
(T
G/
ST
G)
LN
 d
iss
ec
tio
n 
(D
1+
α 
or
 β
/D
2)
O
T 
(m
in
)
Bl
oo
d 
lo
ss 
(m
l)
Nu
m
be
r o
f 
re
se
cte
d 
LN
H
os
pi
ta
l s
ta
y 
(d
)
M
or
bi
di
ty
(%
)
Ki
m
 et
 al
.(2
6)
20
10
Ko
re
a
R
16
0/
16
2/
14
25
9.2
±3
8.9
30
.3±
15
.1
41
.1±
10
.9
5.1
±0
.3
0
L
11
0/
11
3/
8
20
3.9
±3
6.4
44
.7±
37
.1
37
.4±
10
.0
6.5
±0
.8
9
O
12
0/
12
0/
12
12
6.7
±2
4.1
78
.8±
74
.1
43
.3±
10
.4
6.7
±1
.4
16
H
ua
ng
 et
 al
.(3
8)
20
12
Ta
iw
an
R
39
7/
32
5/
34
43
0
  5
0
32
.0±
13
.7
  7
15
.4
L
64
7/
57
52
/1
2
35
0
10
0
26
.0±
12
.4
11
15
.6
O
58
6
17
9/
40
7
70
/5
16
32
0
40
0
34
.0±
14
.8
12
14
.7
R 
= 
ro
bo
tic
; L
 =
 la
pa
ro
sc
op
ic;
 O
 =
 op
en
; T
G 
= 
to
ta
l g
as
tre
cto
m
y; 
ST
G 
= 
su
bt
ot
al 
ga
str
ec
to
m
y; 
LN
 =
 ly
m
ph
 n
od
e; 
O
T 
= 
op
er
ati
ve
 ti
m
e. 
Review Article for Robotic Gastrectomy
69
In terms of intra-operative outcomes, two studies(25,36) find 
a clinical trend in favour of robotic approach with less blood loss, 
although the difference is not statistically significant in the first one. 
In one study,(35) the estimated blood loss difference observed is of 
minimal clinical significance. Any articles has demonstrated that 
the hospital stay of the robotic group was statistically lower than 
the laparoscopic ones, on the contrary, in one report(36) hospital 
stay appears to be on average longer for the robotic group, although 
median days to discharge are similar. Morbidity appears to be lower 
in robotic group for an author,(25) comparable for other ones.(35-37)
Sound oncologic operative outcomes are especially described by 
two studies.(36,37) The second one, that is also the most numerous, 
while not randomized, demonstrates that robotic approach permits 
the experienced surgeon to follow oncologic parameters. None of 
the specimens shows tumor involvement in the resection line in the 
robotic group, unlike the laparoscopic ones. More importantly, the 
number of lymph nodes retrieved for each extent of robotic dissec-
tion is sufficient and does not differ by either method.
Moreover, the confirmation of lesions deeper than T2 in the ro-
botic group seems promising for the future use of robotic assistance 
in treating advanced gastric cancer with D2 lymph node dissection, 
like Pugliese et al.(25) have already told in advance. Having said 
that, all these articles lack in long-term oncological outcomes; only 
one study reports on intermediate survival after RG. Finally, an-
other pitfall of RG is operative time that has been shown to be too 
long by mostly authors.
3) Robotic vs. open vs. laparoscopic gastrectomy
While robot-assisted gastrectomy in the setting of gastric cancer 
has been reported, Kim et al.(26) have been the firsts to compare 
of this technique with the open and laparoscopic ones, even in a 
small group of patients (Table 4). According to the authors, RG of-
fers better short-term surgical outcomes than the open and laparo-
scopic methods in terms of blood loss and hospital stay. The pre-
cision of robotic dissection might help to decrease blood loss and 
transfusion rate and so improve potential survival. Moreover, this 
new technique might decrease the risk of conversion by overcom-
ing the technical limitations of laparoscopy that lead to conversion.
Recently other authors(38) investigated the same aspects in a 
larger group and reported similar results, with the exception of the 
post-operative hospital stay that was longer in the present study 
than other series because the clinical pathway for the laparoscopic 
group is similar to that used initially with the open ones. They also 
underline the substantial robotic advantage in facilitating precise 
lymph node dissection, especially in the infrapyloric and suprapan-
creatic area due to the stability of the camera, the articulation of the 
operating arms and the three-dimensional magnified view. Both 
reports affirm that a longer operation time, as well as higher cost 
and loss of tactile sense, are considered to be the disadvantages of 
robotic surgery in comparison to laparoscopic or open conventional 
surgery.(6)
Future Aspects
1. Operative time and costs
Operating times and cost are at the moment undoubtedly higher 
than in open and laparoscopic gastric surgery. The first one can be 
lowered after completion of the learning curve of both surgical and 
nursing staff as many authors have already published in their tri-
als. With the passing of the time, adequate and better results can be 
achieved; in addition, a patient should not be denied to undergo a 
robotic procedure because of this only parameter,(25) provided that 
the robotic advantages are demonstrated and that it does not entail 
any risk to the patient.
A prompt reduction of costs in the near future is harder to 
achieve and it’s certainly a big limit. Moreover, a detailed analysis 
of cost is still lacking, especially in country where a self-pay health 
care systemis in force. Currently, prospective multicenter studies 
comparing the cost-effectiveness of open vs. laparoscopic gastrec-
tomy(3) and robotic vs. laparoscopic gastrectomy for gastric cancer 
are planned as secondary outcomes of more comprehensive study 
designs (ClinicalTrials.gov. Identifier  NCT01309256).
2. Oncological outcomes
Multi-center, randomized, controlled trials are undoubtedly 
needed to establish the oncological adequacy of RG. The studies 
performed in Korea are done for EGC only and few trials in Eu-
rope have enrolled more advanced gastric cancer stages; the role 
of robotic surgery in both cases, but especially in the second ones, 
remains to be delineated, mainly because it is not yet known which 
is that of laparoscopy.
An interesting aspect that could be investigate in future is in fact 
regarding the role of minimally invasive approach for the treatment 
of advanced gastric cancer. Adjuvant chemoradiation and chemo-
therapy has seemed to increase life expectancy in node-positive 
gastric cancer patients. In the near future, new approaches to gastric 
cancer management will provide novel opportunities of treatment, 
including immunochemotherapy and molecular-targeted therapies.
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In this context, minimally invasive surgery could play a key 
role in improving post-operative course and accelerating times to 
adjuvant treatments,(15) and especially robotic surgery might be a 
correct alternative to laparoscopic approach or the first choice for 
selected cases.
3. Surgeon’s skill
It’s ostensible that robotic system can improve surgeon dexter-
ity by performing more precise and safer operative technique in a 
minimally invasive way due to its technologies, even if it is unprov-
en to date. If it will be demonstrated, this skill could improve expe-
rienced laparoscopic surgeon performance, but could especially be 
a turning point for less accomplished ones. As Jayaraman et al.(39) 
have reported in their article, robotics may allow less experienced 
surgeons with fundamental knowledges to perform more complex 
operations without first developing advanced laparoscopic skills.
Another favourable aspect, is regarding the robotic learning 
curve. In a report comparing the learning curve between conven-
tional laparoscopy and robotic assistance in surgical tasks, some 
authors(40) demonstrate that laparoscopic surgery showed a steep 
learning curve, whereas robot-assisted surgery showed better re-
sults from the beginning of the initial case with a shallower learn-
ing curve, showing the easy adaptability of robot-assisted surgery. 
Further, the growing application of pre-operative simulator tech-
nology in surgical robotics may considerably decrease the learning 
curve of robot-assisted operations(36) and so accelerate the process 
of robotic adoption in gastric surgery.
Conclusion
This systematic review is to date the more recent. Robotic sur-
gery is actually endowed with very interesting aspects and prom-
ising outcomes that could ultimately offer some benefits for the 
treatment of gastric cancer. Larger numbers of studies and more 
specific evaluations are needed to prove it and especially to refute 
pitfalls and disadvantages that are present as well.
On the other hand, as we observed in laparoscopic surgery, to 
validate the role of robotic surgery will take many more years.
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